Sadeghian Fatemeh, Kazemi Faezeh, Pirsadeghi Ali, Asadi Fatemeh, Tashakori Mahnaz, Yousefi-Ahmadipour Aliakbar
Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Department of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Cell Tissue Bank. 2024 Dec 29;26(1):6. doi: 10.1007/s10561-024-10156-x.
Interactions between MSCs and cancer cells are complex and multifaceted and have been shown to exhibit both pro-tumor and antitumor effects. This study investigated the effects of conditioned medium (CM) and cell extract (CE) from two different ERα statuses, MCF-7 and MDA-MB-231 breast cancer cell lines, on adipose-derived mesenchymal stem cells (ASCs). Findings showed that CM and CE increased cellular metabolic activity and viability of ASCs, upregulated angiogenic factors VEGF and HIF-1α, and cytokine TGF-β expression levels. However, CM and CE treatment did not significantly affect the clonogenicity of ASCs. In addition, apoptosis-related genes caspase-3 and 9 showed differential expression patterns among the treatment groups. The findings suggest that breast cancer cell-derived factors can modulate the behavior of ASCs, highlighting their potential as a therapeutic tool in breast cancer treatment and tissue regeneration. However, it is essential to consider the potential risks associated with CM and CE treatment on ASCs, as well as the potential recruitment of ASCs by cancer tumors and the risks associated with this recruitment. Further research is needed to elucidate these potential risks and benefits.
间充质干细胞(MSCs)与癌细胞之间的相互作用复杂且多面,已显示出既有促肿瘤作用,也有抗肿瘤作用。本研究调查了来自两种不同雌激素受体α(ERα)状态的MCF-7和MDA-MB-231乳腺癌细胞系的条件培养基(CM)和细胞提取物(CE)对脂肪来源间充质干细胞(ASCs)的影响。研究结果表明,CM和CE增加了ASCs的细胞代谢活性和活力,上调了血管生成因子血管内皮生长因子(VEGF)和缺氧诱导因子-1α(HIF-1α)以及细胞因子转化生长因子-β(TGF-β)的表达水平。然而,CM和CE处理对ASCs的克隆形成能力没有显著影响。此外,凋亡相关基因半胱天冬酶-3(caspase-3)和半胱天冬酶-9在各处理组中表现出不同的表达模式。这些研究结果表明,乳腺癌细胞衍生因子可以调节ASCs的行为,凸显了它们作为乳腺癌治疗和组织再生治疗工具的潜力。然而,必须考虑CM和CE处理对ASCs的潜在风险,以及癌症肿瘤对ASCs的潜在招募作用及其相关风险。需要进一步研究来阐明这些潜在风险和益处。